Perrigo | PRGO - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
AbbVie USD 6.88B 156M 2026-09
Abbott USD 1.36B 775M 2026-09
Bayer EUR 129M 698M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Corcept Therapeutics USD 114.72M 73.42M 2026-09
Dr.Reddys Laboratories INR 12.16B 8.91B 2026-09
Eli Lilly USD 12.46B 2.68B 2026-06
J&J USD 6.47B 1B 2026-09
Merck USD 7.33B 6.49B 2026-09
Nestle CHF 6.98B 133M 2026-06
Pacira USD 2.57B 2.56B 2026-09
Perrigo USD 27.2M 3.7M 2026-09
Pfizer USD 662M 5M 2026-09
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Reckitt Benckiser GBP 747M 92M 2024-12
Sanofi EUR 4.72B 2.34B 2026-09
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
Xeris Pharmaceuticals USD 5.17M 2.74M 2026-06
Zoetis USD 1.03B 88M 2026-09